DE60307286D1 - Verfahren zur Herstellung von 2-Methyl Piperazine Derivaten. - Google Patents

Verfahren zur Herstellung von 2-Methyl Piperazine Derivaten.

Info

Publication number
DE60307286D1
DE60307286D1 DE60307286T DE60307286T DE60307286D1 DE 60307286 D1 DE60307286 D1 DE 60307286D1 DE 60307286 T DE60307286 T DE 60307286T DE 60307286 T DE60307286 T DE 60307286T DE 60307286 D1 DE60307286 D1 DE 60307286D1
Authority
DE
Germany
Prior art keywords
preparation
methyl piperazine
piperazine derivatives
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60307286T
Other languages
English (en)
Other versions
DE60307286T2 (de
Inventor
Magnus Cernerud
Helena Lundstroem
Claes Loefstroem
Margit Pelcman
Tom Di Fleck
Alexander Paptchikhine
Emma Andersson
Alf Nygren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Cambridge Ltd
Original Assignee
Biovitrum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0201881A external-priority patent/SE0201881D0/xx
Priority claimed from SE0202041A external-priority patent/SE0202041D0/xx
Priority claimed from SE0202516A external-priority patent/SE0202516D0/xx
Application filed by Biovitrum AB filed Critical Biovitrum AB
Publication of DE60307286D1 publication Critical patent/DE60307286D1/de
Application granted granted Critical
Publication of DE60307286T2 publication Critical patent/DE60307286T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
DE60307286T 2002-06-19 2003-06-18 Verfahren zur Herstellung von 2-Methyl Piperazin Derivaten. Expired - Lifetime DE60307286T2 (de)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
SE0201881 2002-06-19
SE0201881A SE0201881D0 (sv) 2002-06-19 2002-06-19 Novel compounds, their use, and preparation
US39065602P 2002-06-21 2002-06-21
US390656P 2002-06-21
SE0202041 2002-06-28
SE0202041A SE0202041D0 (sv) 2002-06-28 2002-06-28 Novel process
US40611902P 2002-08-26 2002-08-26
SE0202516A SE0202516D0 (sv) 2002-08-26 2002-08-26 Novel compounds, their use, and preparation
SE0202516 2002-08-26
US406119P 2002-08-26
US41670102P 2002-10-07 2002-10-07
US416701P 2002-10-07
PCT/SE2003/001043 WO2004000829A1 (en) 2002-06-19 2003-06-18 Novel process

Publications (2)

Publication Number Publication Date
DE60307286D1 true DE60307286D1 (de) 2006-09-14
DE60307286T2 DE60307286T2 (de) 2007-10-25

Family

ID=30004077

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60321606T Expired - Lifetime DE60321606D1 (de) 2002-06-19 2003-06-18 Piperazinylpyrazine als Modulatoren des Serotonin 5-HT2C Rezeptors
DE60307286T Expired - Lifetime DE60307286T2 (de) 2002-06-19 2003-06-18 Verfahren zur Herstellung von 2-Methyl Piperazin Derivaten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60321606T Expired - Lifetime DE60321606D1 (de) 2002-06-19 2003-06-18 Piperazinylpyrazine als Modulatoren des Serotonin 5-HT2C Rezeptors

Country Status (16)

Country Link
EP (2) EP1645558B1 (de)
JP (4) JP4592417B2 (de)
CN (1) CN100334082C (de)
AT (2) ATE334980T1 (de)
AU (1) AU2003237746B8 (de)
CA (1) CA2485532C (de)
CY (1) CY1106225T1 (de)
DE (2) DE60321606D1 (de)
DK (2) DK1645558T3 (de)
ES (2) ES2307102T3 (de)
HK (1) HK1080079B (de)
NO (1) NO20050279D0 (de)
NZ (1) NZ536663A (de)
PT (2) PT1529043E (de)
SI (2) SI1645558T1 (de)
WO (1) WO2004000829A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1792629A4 (de) 2004-08-25 2010-08-25 Takeda Pharmaceutical Mittel zur prävention/behandlung von stressbedingter harninkontinenz und vorsorgeuntersuchungsverfahren dafür
EP2742936A1 (de) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Kondensierte heterocyclische Verbindung und ihre Verwendung
US8232287B2 (en) 2007-10-16 2012-07-31 Daiichi Sankyo Company, Limited Pyrimidyl indoline compound
JP5520051B2 (ja) 2007-11-15 2014-06-11 武田薬品工業株式会社 縮合ピリジン誘導体およびその用途
GEP20146168B (en) 2009-06-15 2014-09-25 Takeda Pharmaceuticals Co Pyrazinooxazepine derivatives
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
GB201304811D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Novel treatment for hypertension
JPWO2019131902A1 (ja) 2017-12-27 2020-12-10 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06306075A (ja) * 1993-04-23 1994-11-01 Sanwa Kagaku Kenkyusho Co Ltd エトキシベンズアミド誘導体
BR0010783A (pt) * 1999-05-21 2002-04-09 Biovitrum Ab Novos compostos, seu uso e preparação
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
EP1337518B1 (de) * 2000-11-20 2009-06-17 Biovitrum AB (publ) Piperazinylpyrazinverbindungen als antagonisten des serotonin-5-ht2-rezeptors

Also Published As

Publication number Publication date
CA2485532C (en) 2012-03-06
CN100334082C (zh) 2007-08-29
PT1529043E (pt) 2006-12-29
DK1645558T3 (da) 2008-10-06
EP1645558B1 (de) 2008-06-11
WO2004000829A1 (en) 2003-12-31
PT1645558E (pt) 2008-07-30
EP1645558A1 (de) 2006-04-12
DK1529043T3 (da) 2006-12-04
NO20050279D0 (no) 2005-01-18
EP1529043B1 (de) 2006-08-02
AU2003237746B2 (en) 2009-12-17
JP4592417B2 (ja) 2010-12-01
DE60321606D1 (de) 2008-07-24
CA2485532A1 (en) 2003-12-31
SI1645558T1 (sl) 2008-10-31
HK1080079B (zh) 2008-03-14
JP2010120949A (ja) 2010-06-03
CN1662523A (zh) 2005-08-31
CY1106225T1 (el) 2011-06-08
EP1529043A1 (de) 2005-05-11
HK1080079A1 (en) 2006-04-21
ES2270051T3 (es) 2007-04-01
ATE398119T1 (de) 2008-07-15
JP2013116906A (ja) 2013-06-13
NZ536663A (en) 2007-05-31
AU2003237746A1 (en) 2004-01-06
ATE334980T1 (de) 2006-08-15
JP2013227336A (ja) 2013-11-07
JP2005537316A (ja) 2005-12-08
JP5378241B2 (ja) 2013-12-25
ES2307102T3 (es) 2008-11-16
DE60307286T2 (de) 2007-10-25
AU2003237746B8 (en) 2010-01-28
SI1529043T1 (sl) 2006-12-31

Similar Documents

Publication Publication Date Title
BR0311494A (pt) Novos indóis substituìdos
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
RS28004A (en) Azabicycle-substituted fused- heteroaryl compounds for the treatment of disease
NO20055591L (no) Antivirale fosfonatanaloger
DE60124085D1 (de) Pde-v hemmer zur behandlung von morbus parkinson
IS6459A (is) Arýl sambrædd azapólýsýklísk efnasambönd
BR0312729A (pt) Novos derivados de indol-3-enxofre
EA200600317A1 (ru) Производные омега-карбоксиарилдифенилмочевины (варианты), фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с их использованием (варианты)
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
HK1080079A1 (en) A process for the preparation of 2-methylpiperazine derivative
DK1745010T3 (da) Substituerede cyklohexyl-1,4-diaminderivater
ATE437855T1 (de) (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit
DE602006009556D1 (de) Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen
MXPA05010020A (es) Derivados de oxamida.
EA200700707A1 (ru) Производные 2-ациламинотиазола
MA27745A1 (fr) Derives d'acide benzoylureidopyridyl-piperidine et pyrrolidinecarboxylique substitues, methode de production de ceux-ci et utilisation de ceux-ci.
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
DE602006007682D1 (de) 2,5-disubstituierte phenylmethanonderivative als glycintransporter-1-inhibitoren (glyt-1) zur behandlung von neurologischen und neuropsychiatrischen störungen
EA200401432A1 (ru) Сложноэфирные производные декагидроизохинолин-3-карбоновой кислоты в качестве анальгетиков
ATE369849T1 (de) Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PROXIMAGEN LTD., LONDON, GB